Aurozyme: A Revolutionary Nanozyme in Colitis, Switching Peroxidase‐Like to Catalase‐Like Activity (Small 41/2023)

Aurozymes Aurozyme, a novel nanozyme, effectively treats inflammatory bowel disease (IBD). Composed of gold nanoparticles and glycyrrhizin with a glycol chitosan coating, it scavenges harmful radicals and molecular patterns in colitis. Aurozyme's unique catalase-like activity converts hydroxyl radicals to water and oxygen, reducing inflammation and promoting tissue repair. It also regulates gut microbiota, demonstrating its transformative potential for managing chronic inflammatory conditions. More details can be found in article number 2302331 by Dong Yun Lee and co-workers.